Abstract:Silk fibroin (SF) is a biomacromolecule that can be assembled into nanostructures and induce biomimetic nucleation of inorganic materials. Zeolitic imidazolate framework-8 (ZIF-8), a metal–organic framework (MOF), can be dissolved selectively under acidic pH. Here, we integrated SF and ZIF-8 to develop novel drug carriers that selectively release drug in the acidic intracellular environment of cancer cells. Specifically, SF was assembled into nanoparticles (SF-NPs), which were then loaded with an antitumor drug, doxorubicin (DOX), to form DSF-NPs. Due to the SF-mediated organization of ZIF-8 precursors such as zinc ions, the DSF-NPs further templated the nucleation of ZIF-8 onto their surface to generate core–shell-structured NPs (termed ) with ZIF-8 as a shell and DSF-NP as a core. We found that the , highly stable under neutral conditions, could be uptaken by breast cancer cells, release DOX selectively owing to dissolution of ZIF-8 shells in the acidic intracellular environment in a controlled manner, and induce cell apoptosis. We also confirmed that the could inhibit tumor growth more efficiently to reach a higher survival rate than their controls by inducing cell apoptosis in vivo. Our study suggests that SF and MOF could be combined to design a new type of cancer therapeutics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c13405.Materials characterization, intracellular location, and biocompatibility; elemental line mapping of ; FTIR spectra of ZIF-8, , and SF-NPs; size distribution of DSF-NPs and ; loading capacity and EE of DOX onto SF-NPs with various concentrations; relative viability of MCF-7 cells cocultured with NPs; fluorescent images of the MCF-7 cells cocultured with FITC-labeled NPs; TEM images of (50 μg/mL) cocultured with MCF-7 cells for 12 h; H&E staining of normal organs (heart, spleen, lung, liver, and kidney) excised from the mice bearing MCF-7 tumors and treated with different NPs and their controls; polydispersity index of DSF-NPs and ; and chemical element analysis of (PDF)This article has not yet been cited by other publications.

Orderly Curled Silica Nanosheets with a Small Size and Macromolecular Loading Pores: Synthesis and Delivery of Macromolecules to Eradicate Drug-Resistant Cancer.

Biphasic synthesis of biodegradable urchin-like mesoporous organosilica nanoparticles for enhanced cellular internalization and precision cascaded therapy

Polytonic Drug Release via Multi-Hierarchical Microstructures Enabled by Nano-Metamaterials

Facile Synthesis of Monodisperse Hollow Mesoporous Organosilica/Silica Nanospheres by an in Situ Dissolution and Reassembly Approach

Template-Free Synthesis of Chemically Asymmetric Silica Nanotubes for Selective Cargo Loading and Sustained Drug Release

Nucleation and Assembly of Silica into Protein-Based Nanocomposites as Effective Anticancer Drug Carriers Using Self-Assembled Silk Protein Nanostructures as Biotemplates.

Walnut kernel-like mesoporous silica nanoparticles as effective drug carrier for cancer therapy in vitro

Design of Dendritic Large-Pore Mesoporous Silica Nanoparticles with Controlled Structure and Formation Mechanism in Dual-Templating Strategy

Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for Ph and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.

Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery

Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

Facile Synthesis of Yolk-Shell Structured Monodisperse Mesoporous Organosilica Nanoparticles by a Mild Alkalescent Etching Approach.

Multiple-Responsive Mesoporous Silica Nanoparticles for Highly Accurate Drugs Delivery to Tumor Cells

Urchin-like Porous Silica Nanoparticles for Simultaneous Intracellular Delivery of Doxorubicin and RNase A

Deformable Double-Shelled Hollow Mesoporous Organosilica Nanocapsules: A Multi-Interfacial Etching Strategy

Synthesis of Discrete and Dispersible Hollow Mesoporous Silica Nanoparticles with Tailored Shell Thickness for Controlled Drug Release

A Preloaded Amorphous Calcium Carbonate/Doxorubicin@Silica Nanoreactor for Ph‐responsive Delivery of an Anticancer Drug

Superstable and Large-Scalable Organosilica-Micellar Hybrid Nanosystem via a Confined Gelation Strategy for Ultrahigh-Dosage Chemotherapy

Mesoporous Silica Nanoparticles with Manipulated Microstructures for Drug Delivery

Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment

Gold Nanorods with Silica Shell and PAMAM Dendrimers for Efficient Photothermal Therapy and Low Toxic Codelivery of Anticancer Drug and Sirna